LyfeSci Research & Innovation, a newly founded physician-led Contract Research Organization (CRO), proudly announces its launch. With a site-first philosophy and a commitment to patient outcomes, LyfeSci blends deep clinical expertise with patient-centered strategies to deliver comprehensive research services spanning pre-clinical studies through Real-World Evidence (RWE) and Real-World Data (RWD) research.

“Our goal is to revolutionize the clinical research experience by placing patients at the heart of everything we do,” said Tapan Parikh, MD, CEO and Founder. “By delivering value that reflects site needs—which in turn address patient priorities and clinical realities—we aim to improve study timelines and elevate the quality of research outcomes by leveraging our scientific expertise and technology capabilities.”

The organization emphasizes seamless collaboration across stakeholders, offering tailored solutions that streamline operations, reduce burdens on investigators, and enhance patient experiences throughout the research lifecycle. Core services include pre-clinical studies, IND preparation and submission, full-scale clinical trial management, biostatistics, pharmacovigilance, and RWE/RWD analysis.

“By evaluating new therapies through a real-world clinical lens, we design studies that truly matter to both patients and healthcare providers,” said William Gannon Jr., MD, Chief Medical Officer, an industry veteran with more than 35 years of experience across major CROs and sponsors of all sizes. “Our mission is to ensure clinical trials are accessible, practical for sites, valuable for sponsors, and ultimately transformative for patients.”

The leadership team brings extensive clinical experience and industry insight, ensuring every aspect of LyfeSci’s service delivery aligns with patient and clinician expectations.

For more details or to explore collaboration opportunities, visit www.LyfeSci.com or contact Myra Zerr-Korolev at mzerr@lyfesci.com.

About LyfeSci

LyfeSci is a physician-founded CRO dedicated to transforming clinical research through patient-centered methodologies and strong partnerships with clinical sites and sponsors. By integrating clinical expertise with outcome-focused innovation, LyfeSci advances therapeutic development and improves health outcomes across diverse therapeutic areas worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251021854043/en/

“Revolutionizing clinical research by putting patients—and the sites that serve them—at the center of every study.”